Approved revisions

View list of: Pages whose approved revision is not their latest | Unapproved pages | All pages with an approved revision | Pages with invalid approvals

Showing below up to 50 results in range #51 to #100.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. 11. Amino acid metabolism; the fate of the amino group (revision 1380, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  2. 11. Anthracosis of lymph node (revision 4465, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  3. 11. Biochemistry of blood vessels (revision 1574, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  4. 11. Clinical biochemistry of osteoporosis. Laboratory tests to assess joint and bone disorders. (revision 4048, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  5. 11. Describe the body fluid compartments and explain the methods used for measurement of body fluid volumes (revision 1215, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  6. 11. Dietary supplements and functional foods (revision 1113, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  7. 11. Diseases of the aorta. Imaging methods, the role of CT and MRI. (revision 3299, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  8. 11. Drug formulations. Prescription writing (revision 1982, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  9. 11. Extrafollicular and germinal centre reactions (revision 1500, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  10. 11. Formation and derivatives of the heart tube. Partitioning of the cardiac chambers. Malformations (revision 1651, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  11. 11. Haemochromatosis (revision 4441, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  12. 11. Hemoglobinogenic pigments I. Causes and forms of jaundice (revision 229, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  13. 11. Hepatic lesions caused by circulatory disorders. Nonviral inflammatory diseases of the liver. Drug hepatopathies (revision 61, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  14. 11. Hyalinised glomeruli (revision 4691, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  15. 11. Linitis plastica and Krukenberg tumor (revision 703, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  16. 11. Minorities: Health issues and disparities (revision 1073, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  17. 11. Obstipation, subileus, diverticulosis. GIT motility disorders (revision 1858, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  18. 11. Oncologic emergencies (revision 5010, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  19. 11. Otosclerosis, tympanosclerosis (revision 3079, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  20. 11. Risk factors of malignant diseases (revision 3477, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  21. 11. Vasovagal syncope (revision 1700, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  22. 110. Health effects of soil contamination. Health effects and management of wastewater, wastes and hazardous wastes (revision 1184, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  23. 111. Risk assessment, management, and communication (revision 1185, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  24. 112. Occupational toxicology, chemical safety (revision 1186, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  25. 113. Occupational cancers (revision 1187, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  26. 114. Physical hazards: health effects of low and high temperature (revision 1188, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  27. 115. Physical hazards: disorders caused by noise and vibration and their prevention (revision 1189, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  28. 116. Chemical hazards: Industrial and agricultural toxicology of organic compounds (revision 1190, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  29. 117. Chemical hazards: Industrial and agricultural toxicology of inorganic compounds (revision 1191, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  30. 118. Psychosocial and biological hazards in the workplace (revision 1192, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  31. 119. Health effects of ionizing and non-ionizing radiations (revision 1193, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  32. 11A. Types of epilepsy (+ epileptic seizures and PNES) (revision 2230, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  33. 11B. Potentially reversible dementias (revision 2231, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  34. 11 – Adult foot deformities + static disorders of the foot (revision 5304, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  35. 12. Acute pancreatitis. Pathophysiology and consequences (revision 1859, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  36. 12. Acute viral hepatitis (aetiology, pathomorphology, complicated forms) (revision 1811, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  37. 12. Amyloidosis of the liver (revision 4466, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  38. 12. B-cell affinity maturation and isotype switching (revision 1503, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  39. 12. Chronic osteomyelitis (Garre, Brodie’s abscess) (revision 5271, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  40. 12. Definition and classification of circulatory shock. Pathophysiology of development, phases and characteristics of microcirculation (revision 1703, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  41. 12. Describe the major plasma proteins and the other non-electrolytic constituents of blood and explain their function in the body (revision 1221, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  42. 12. Development of the kidney and the urinary tract. Malformations (revision 1652, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  43. 12. Drug research and development (revision 1983, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  44. 12. Echinococcus cysts in the liver (revision 705, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  45. 12. Fluid systems of the labyrinth, Meniere’s disease, toxic lesions of the inner ear (revision 3082, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  46. 12. Food additives (revision 1114, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  47. 12. Health issues and disparities of people living with disabilities (revision 1074, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  48. 12. Hemoglobinogenic pigments II. Pathological forms of iron storage (revision 230, approved by 127.0.0.1 on 26 November 2024 at 10:56)
  49. 12. Imaging in acute abdomen. (revision 3361, approved by 127.0.0.1 on 26 November 2024 at 10:57)
  50. 12. Kimmelstiel Wilson syndrome (revision 4693, approved by 127.0.0.1 on 26 November 2024 at 10:56)

View ( | ) (20 | 50 | 100 | 250 | 500)